FR190997, a novel bradykinin B2 agonist, expresses longer action than bradykinin in paw edema formation and hypotensive response

Immunopharmacology

Volumn 45, Issue 1-3, 1999, Pages 89-93

  Ueno, Akinori ^a   Naraba, Hiroaki ^a   Kojima, Fumiaki ^a   Morita, Eishi ^a   Oh ishi, Sachiko ^a  

^a School of Pharmaceutical Sciences   (Japan)

Author keywords

Bradykinin B2 receptor; FR173657; FR190997; Hypotension; Paw edema

Indexed keywords

3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE; 8 [2,6 DICHLORO 3 [N [4 (N METHYLCARBAMOYL)CINNAMAMIDOACETYL] N METHYLAMINO]BENZYLOXY] 2 METHYL 4 (2 PYRIDYLMETHOXY)QUINOLINE; BRADYKININ; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; ICATIBANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HYPOTENSION; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD PRESSURE; BRADYKININ; EDEMA; HINDLIMB; HYPOTENSION; MALE; MICE; MICE, INBRED ICR; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, BRADYKININ;

EID: 0032726682     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(99)00148-4     Document Type: Article

References (11)

1. Aramori I., Zenkoh J., Morikawa N., Asano M., Hatori C., Sawai H., Kayakiri H., Satoh S., Inoue T., Abe Y., Sawada Y., Mizutani T., Inamura N., Nakahara K., Kojo H., Oku T., Notsu Y. Nonpeptide mimic of bradykinin with long-acting properties at the bradykinin B2 receptor. Mol. Pharmacol. 52:1997;16-20.
2. Asano M., Inamura N., Hatori C., Sawai H., Fujisawa T., Katayama A., Kayakiri H., Satoh S., Abe Y., Inoue T., Sawada Y., Nakahara K., Oku T., Okuhara M. The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657. Br. J. Pharmacol. 120:1997;617-624.
3. Coleman, R.W., Wong, P.Y., 1979. Kallikrein-kinin system in pathologic conditions. In: Erdos, E.G. (Ed.), Handbook of Experimental Pharmacology, 25 Suppl. Bradykinin, Kallidin and Kallikrein. Springer, Berlin, pp. 569-607.
4. Dozen M., Yamaki K., Oh-ishi S. Captopril uncovers kinin-dependent release of arachidonic acid metabolites in carrageenin-induced rat pleurisy. Jpn. J. Pharmacol. 51:1989;101-105.
5. Majima M., Kawashima N., Ito H., Katori M. Effect of an orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy. Br. J. Pharmacol. 121:1997;723-730.
6. Oh-ishi S., Hayashi I., Utsunomiya I., Hayashi M., Yamaki K., Yamasu A., Nakano T. Roles of kallikrein-kinin system in acute inflammation: studies on high- and low-molecular weight kininogen-deficient rats (B/N-Katholiek strain). Agent and Action. 21:1987;384-396.
7. Regoli D., Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32:1980;1-46.
8. 9-bradykinin in young Brown/Norway rats pretreated with endotoxin. Eur. J. Pharmacol. 274:1995;225-228.
9. Ueno A., Naraba H., Oh-ishi S. Mouse paw edema induced by a novel bradykinin agonist and its inhibition by B2-antagonists. Jpn. J. Pharmacol. 78:1998;109-111.
10. Vane J.R. The release and fate of vaso-active hormones in the circulation. Br. J. Pharmacol. 35:1969;209-242.
11. Wirth K., Hock F.J., Albus U., Linz W., Alpermann H.G., St. Henke H.A., Breipohl G., Konig W., Knolle J., Scholkens B.A. Hoe 140, a new potent and long acting bradykinin-antagonist: in vivo studies. Br. J. Pharmacol. 102:1991;774-777.